#United States #Dublin, Ohio #Epiq Animal Health #Interpath Global #Epiitalis

Epiq Animal Health and Interpath Global Introduce 4CYTE™ for Dogs

In a significant advancement for pet care, epiq Animal Health and Interpath Global have officially launched their second health product, 4CYTE™ for dogs, through a collaborative partnership formed in December. This innovative nutraceutical is formulated to promote joint health in canine companions, reflecting the companies' commitment to enhancing animal well-being through scientific research and development.

Understanding 4CYTE™ and Its Unique Ingredients

4CYTE™ is specially designed for dogs and is built around its key ingredient, Epiitalis®, which is a patented formulation derived from plant seed oil rich in essential fatty acids. This groundbreaking ingredient has been the subject of extensive scientific study and is recognized for its digestibility and absorption qualities, making it not only effective but also easy for dogs to consume. Previously available only in foreign markets, 4CYTE™ has been adapted to meet the needs of the U.S. pet health market, thanks to rigorous testing since 2008, which has included laboratory evaluations, in vivo studies, and multiple clinical trials.

The efficacy of Epiitalis® has been validated in peer-reviewed articles published in reputable international journals, asserting its role in promoting joint health across various species, including dogs and horses. This scientific backing positions 4CYTE™ as a front-runner in an increasingly competitive pet health product market.

What the Experts Say

Rebecca Britton, the General Manager at epiq Animal Health, expressed her enthusiasm at the launch, stating, "We couldn't be more excited to bring 4CYTE™, a revolutionary advanced health supplement scientifically proven to enhance joint health function in horses and dogs to the US market. The feedback from horse and dog owners around the world, and most importantly the exceptional clinical outcomes for the animals themselves are second to none." This affirmation not only highlights the effectiveness of the product but also emphasizes the positive impacts it has on the pets' health, a core concern for pet owners.

Collaborative Efforts and Future Goals

As part of their partnership, epiq Animal Health and Interpath Global have worked diligently to enhance supply chain solutions, aiming to ensure that veterinarians and animal health professionals can easily access these novel products. 4CYTE™ for dogs complements the horse product that was launched earlier, showcasing a comprehensive approach to animal nutrition. This effort isn't limited to just distribution; the companies are also committed to educating and training the animal health community in the United States about the unique benefits and applications of their products, thereby ensuring that both the veterinary community and pet owners receive up-to-date information on the importance of joint health.

Availability and Distribution

Currently, 4CYTE™ for dogs is accessible through Covetrus, a prominent distributor in the animal health sector, with more partnerships on the horizon. Pet owners can also find their horse product on SmartPak and the dog supplement on Amazon, providing multiple channels for consumers to purchase these innovative joint health products. As the demand for high-quality pet health supplements continues to rise, the introduction of 4CYTE™ is a timely addition to the market.

Looking Ahead

Epiq Animal Health's mission is to collaborate with leading manufacturers and distributors in the animal health industry to deliver innovative and effective solutions for veterinary professionals and pet owners alike. Their partnership with Interpath Global is a testament to this mission, blending state-of-the-art research with community education to boost animal health outcomes in the U.S.

To learn more about epiq Animal Health and 4CYTE™, visit their website at epiq-ah.com, or for inquiries, reach them via email at [email protected]. This strategic partnership not only has the potential to improve joint health in dogs but also reinforces the ongoing commitment of both companies to elevate standards in the animal health sector.